G protein-coupled receptor-44 (GPR-44) antagonist (AstraZeneca/Oslo University Hospital)

N/A

Report date: 2025/01/26 18:56:01
NME

Base Information

Drug NameG protein-coupled receptor-44 (GPR-44) antagonist (AstraZeneca/Oslo University Hospital)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonists
TargetsProstaglandin D2 receptor 2
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorwayUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesOslo Universitetssykehus HfAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A